Company ProfilePremium

Synergy Pharmaceuticals Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Synergy Pharmaceuticals Inc. - Healthcare showcase

Year Founded & Workforce

2005

155 Employees

Industry

Healthcare

Services

IBS
S

Synergy Pharmaceuticals Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Synergy Pharmaceuticals Inc. Overview

Company Headquarter: New York, US

Founded: 2005

Workforce: 155+ employees

Company Working: Synergy Pharmaceuticals Inc. is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies. The company holds 100% worldwide rights to the proprietary uroguanylin based GI platform that includes one commercial product, TRULANCE (plecanatide), and a second lead product candidate, dolcanatide.

Company Snapshot

155

Employees

2005

Founded

SWOT Analysis

Strengths

  • Innovative product line
  • Well-established research and development

Weaknesses

  • No global presence
  • Low revenues

Opportunities

  • Growing demand for products can increase market growth

Threats

  • Stringent government regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
–FDA ApprovalDevelopments The company received the FDA approval for Trulance, a drug for the treatment of IBS.

Product Offering

  • Synergy Pharmaceuticals Inc.
    • IBS

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.